1. Home
  2. LITB vs MNOV Comparison

LITB vs MNOV Comparison

Compare LITB & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LITB

LightInTheBox Holding Co. Ltd.

N/A

Current Price

$3.23

Market Cap

57.1M

ML Signal

N/A

Logo Medicinova Inc

MNOV

Medicinova Inc

N/A

Current Price

$1.33

Market Cap

67.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LITB
MNOV
Founded
2007
2000
Country
Singapore
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.1M
67.9M
IPO Year
2013
2004

Fundamental Metrics

Financial Performance
Metric
LITB
MNOV
Price
$3.23
$1.33
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
3.8K
37.0K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,360,807.00
Revenue This Year
$14.50
N/A
Revenue Next Year
$11.59
$180.00
P/E Ratio
$10.96
N/A
Revenue Growth
N/A
194.15
52 Week Low
$1.15
$1.17
52 Week High
$4.17
$1.96

Technical Indicators

Market Signals
Indicator
LITB
MNOV
Relative Strength Index (RSI) 47.15 47.47
Support Level $2.81 $1.30
Resistance Level $3.36 $1.46
Average True Range (ATR) 0.22 0.04
MACD -0.03 -0.00
Stochastic Oscillator 35.00 33.33

Price Performance

Historical Comparison
LITB
MNOV

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is a e-commerce company, providing a diverse range of affordable lifestyle products directly to consumers. Its brands include Ador, a women's fashion brand targeting women aged 35-55; the second is a golf apparel brand focusing on female golfers aged 35 and above; the third is a women's light party dress brand for the age group of 30 and above. It offers customers products through websites and mobile applications. The company operates and reviews its performance in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of the provision of logistic services to companies and individual customers.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Share on Social Networks: